Protein therapeutics – lessons learned and a view of the future
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.6.1.1
Reference44 articles.
1. Enzyme Replacement Therapy of Fabry Disease
2. Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
3. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein
4. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor
5. Interleukin-18 Binding Protein
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recombinant human scFv antibody fragments against phospholipase A2 from Naja naja and Echis carinatus snake venoms: In vivo neutralization and mechanistic insights;Molecular Immunology;2024-01
2. Antibodies against Elapidae and Viperidae snake venoms: in vivo neutralization and mechanistic insights;2023-06-16
3. Modulation of Cellular Senescence in HEK293 and HepG2 Cells by Ultrafiltrates UPla and ULu Is Partly Mediated by Modulation of Mitochondrial Homeostasis under Oxidative Stress;International Journal of Molecular Sciences;2023-04-04
4. Introduction to Protein Therapeutics;Protein-based Therapeutics;2023
5. Development of a Potent Cyclic Peptide Inhibitor of the nNOS/PSD-95 Interaction;Journal of Medicinal Chemistry;2022-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3